Your browser doesn't support javascript.
loading
Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy.
Wei, Andrew H; Panayiotidis, Panayiotis; Montesinos, Pau; Laribi, Kamel; Ivanov, Vladimir; Kim, Inho; Novak, Jan; Champion, Rebecca; Fiedler, Walter; Pagoni, Maria; Bergeron, Julie; Ting, Stephen B; Hou, Jing-Zhou; Anagnostopoulos, Achilles; McDonald, Andrew; Murthy, Vidhya; Yamauchi, Takahiro; Wang, Jianxiang; Jiang, Qi; Sun, Yan; Chyla, Brenda; Mendes, Wellington; DiNardo, Courtney D.
Afiliação
  • Wei AH; The Peter MacCallum Cancer Centre, Royal Melbourne Hospital and Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Panayiotidis P; National and Kapodistrian University of Athens Medical School, Laiko General Hospital, Athens, Greece.
  • Montesinos P; Hospital Universitario y Politécnico La Fe, Valencia, Spain and CIBERONC, Instituto Carlos III, Madrid, Spain.
  • Laribi K; Centre Hospitalier-Le Mans, Le Mans, France.
  • Ivanov V; Almazov National Medical Research Center, Saint Petersburg, Russia.
  • Kim I; Seoul National University Hospital, Seoul, Republic of Korea.
  • Novak J; Department of Internal Medicine and Hematology, University Hospital Královské Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Champion R; Norton Cancer Institute, Louisville, KY.
  • Fiedler W; Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Pagoni M; Evaggelismos General Hospital, Athens Greece.
  • Bergeron J; CIUSSS-EMTL, Installation Maisonneuve-Rosemont, Montreal, Quebec City, Canada.
  • Ting SB; Eastern Health and Monash University, Melbourne, Victoria, Australia.
  • Hou JZ; University of Pittsburgh Medical Center (UPMC) Cancer Center, Pittsburgh, PA.
  • Anagnostopoulos A; George Papanicolaou General Hospital, Thessalonica, Greece.
  • McDonald A; Netcare Pretoria East Hospital, Moreletapark, Pretoria, South Africa.
  • Murthy V; Heartlands Hospital, Birmingham, United Kingdom.
  • Yamauchi T; University of Fukui Hospital, Fukui, Japan.
  • Wang J; Chinese Academy of Medical Sciences, Tianjin, China.
  • Jiang Q; AbbVie Inc., North Chicago, IL.
  • Sun Y; AbbVie Inc., North Chicago, IL.
  • Chyla B; AbbVie Inc., North Chicago, IL.
  • Mendes W; AbbVie Inc., North Chicago, IL.
  • DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Blood ; 140(25): 2754-2756, 2022 12 22.
Article em En | MEDLINE | ID: mdl-36112968
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Idioma: En Ano de publicação: 2022 Tipo de documento: Article